Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other Accumulated Expenses (2019 - 2025)

Precision Biosciences (DTIL) has disclosed Other Accumulated Expenses for 7 consecutive years, with $611000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 55.88% to $611000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $611000.0, a 55.88% decrease, with the full-year FY2024 number at $989000.0, down 58.64% from a year prior.
  • Other Accumulated Expenses was $611000.0 for Q3 2025 at Precision Biosciences, down from $721000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.8 million in Q1 2024 to a low of $611000.0 in Q3 2025.
  • A 5-year average of $1.5 million and a median of $1.4 million in 2023 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: surged 220.94% in 2023, then plummeted 67.68% in 2025.
  • Precision Biosciences' Other Accumulated Expenses stood at $977000.0 in 2021, then dropped by 23.75% to $745000.0 in 2022, then soared by 220.94% to $2.4 million in 2023, then tumbled by 58.64% to $989000.0 in 2024, then crashed by 38.22% to $611000.0 in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Other Accumulated Expenses are $611000.0 (Q3 2025), $721000.0 (Q2 2025), and $896000.0 (Q1 2025).